FDA Adverse Event Injury Summary report: N

GORE EXCLUDER AAA ENDOPROSTHESIS

MDR report key: 2820617 · Received October 29, 2012

Report

Report Number
2953161-2012-00193
Event Type
Injury
Date Received
October 29, 2012
Date of Event
September 28, 2012
Report Date
October 2, 2012
Manufacturer
W. L. GORE & ASSOCIATES
Product Code
MIH
PMA / PMN Number
P020004
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
IL, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THE REVIEW OF THE MANUFACTURING PAPERWORK VERIFIED THAT THIS LOT MET ALL PRE-RELEASE SPECIFICATIONS.

Description of Event or Problem · 1

ON (B)(6) 2011, THIS PATIENT UNDERWENT TREATMENT OF AN ABDOMINAL AORTIC ANEURYSM WITH THREE GORE EXCLUDER AAA ENDOPROSTHESES. ON (B)(6) 2012, FOLLOW-UP ANGIOGRAPHY SHOWED EITHER A PROXIMAL TYPE I ENDOLEAK OR A TYPE III ENDOLEAK REPORTEDLY DUE TO A HOLE IN THE TRUNK. IT WAS REPORTED THE DEVICE HAD MIGRATED DISTALLY 7 MM FROM THE RENAL ARTERIES, AND THE ANEURYSM HAD GROWN FROM 5 TO 5.8 CM. THE CONTRAST IS REPORTEDLY SHOWING 47 MM DISTAL TO THE TOP OF THE DEVICE. ON (B)(6) 2012, AN INTERVENTION WAS PERFORMED TO TREAT THE ENDOLEAK. IT WAS REPORTED THAT A HOLE IN THE PXT231416 WAS SEEN AT THE BOTTOM OF THE NECK BEFORE THE BIFURCATION. IT IS UNKNOWN WHAT CAUSED THE REPORTED HOLE. THE ORIGINALLY IMPLANTED DEVICES WERE RELINED WITH FOUR ADDITIONAL GORE EXCLUDER AAA ENDOPROSTHESES. FINAL ANGIOGRAPHY SHOWED NO EVIDENCE OF THE TYPE III ENDOLEAK, AND THE PATIENT TOLERATED THE PROCEDURE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 GORE EXCLUDER AAA ENDOPROSTHESIS MIH / SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT MIH W. L. GORE & ASSOCIATES 8293466

Patients

Seq Age Sex Outcome Treatment
1 85 YR Hospitalization| R HYDROCHLOROZINE| ZINC| CALCIUM CITRATE| TRIMINASOL| RANITIDINE| PLAVIX| PRILOSEC| CLOBETAZOLE| MAGNESIUM